About this trial
The study aims to recruit at least 952 participants in Europe over a 32-month period. Patients undergoing surgery for oesophageal or stomach cancer will be invited to participate in the study at around 4 to 8 weeks after their surgery.
(i) The imaging surveillance group will receive a review in clinic or by telephone with a member of the surgical team, and a radiological scan at 6, 12, 18, 24, 30 and 36 months after randomisation. They will also receive endoscopy at 12 months after randomisation (ii) The clinical surveillance group will receive a review in clinic or by telephone at 6, 12, 18, 24, 30 and 36 months. After this they will be either discharged to their local doctor or receive a review in clinic with a member of the surgical team every year according to local practice
Patient Profile
The SARONG-II trial will recruit adults (aged 18 years or over) receiving surgical resection for curatively intended treatment of oesophageal or gastric cancer with or without neoadjuvant/adjuvant chemo(radio)therapy. Patients must be willing and able to give informed consent.
Where’s this trial being run?
St James’s Hospital
Can I join this study / trial?
The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.
It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.
For more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | SARONG-II Trial |
|---|---|
| Number: | CTRIAL-IE 24-01 |
| Full Title: | Open label international multicentre randomised controlled trial of intensive surveillance vs. standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer (Surveillance After Resection of Oesophageal aNd Gastric cancer |
| Principal Investigator: | Dr Jessie Elliot |
|---|---|
| Type: | Collaborative |
| Sponsor: | Trinity St James’s Cancer Institute |
| Recruitment Started: |
Global: May 2024 Ireland: May 2024 |
| Global Recruitment Target: | 952 |
|---|---|
| Ireland Recruitment Target: | To be confirmed |